CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances.
Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, Cherif H, Uddin S, Steinhoff M, Marincola FM, Dermime S.
Mol Cancer. 2023 Jan 30;22(1):20. doi: 10.1186/s12943-023-01723-z.
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.
Huang Y, Hong W, Wei X.
J Hematol Oncol. 2022 Sep 8;15(1):129. doi: 10.1186/s13045-022-01347-8.
Cancer immunotherapies: advances and bottlenecks.
Rui R, Zhou L, He S.
Front Immunol. 2023 Aug 24;14:1212476. doi: 10.3389/fimmu.2023.1212476. eCollection 2023.
The microbiome and human cancer.
Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R.
Science. 2021 Mar 26;371(6536):eabc4552. doi: 10.1126/science.abc4552.
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.
Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, Ping Y, Zhang Y.
J Hematol Oncol. 2021 Nov 6;14(1):187. doi: 10.1186/s13045-021-01200-4.
Immunosenescence: a key player in cancer development.
Lian J, Yue Y, Yu W, Zhang Y.
J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z.
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L.
Ann Oncol. 2016 Aug;27(8):1482-92. doi: 10.1093/annonc/mdw168. Epub 2016 Apr 10.
cGAS-STING pathway in cancer biotherapy.
Wang Y, Luo J, Alu A, Han X, Wei Y, Wei X.
Mol Cancer. 2020 Sep 4;19(1):136. doi: 10.1186/s12943-020-01247-w.
Turning cold tumors hot: from molecular mechanisms to clinical applications.
Zhang J, Huang D, Saw PE, Song E.
Trends Immunol. 2022 Jul;43(7):523-545. doi: 10.1016/j.it.2022.04.010. Epub 2022 May 25.
The theory of tumor ecosystem.
Chen X, Song E.
Cancer Commun (Lond). 2022 Jul;42(7):587-608. doi: 10.1002/cac2.12316. Epub 2022 Jun 1.
